Literature DB >> 1377467

Developments in the control of testicular function.

R S Swerdloff, C Wang, S Bhasin.   

Abstract

Clinicians and clinical investigators have developed improved means for controlling testicular function in men. New and refined approaches for stimulation and inhibition of the hypothalamic-pituitary-testicular axis are now available. This chapter reviewed the most successful ways to inhibit the reproductive axis in men and its current application to the treatment of precocious puberty, metastatic prostate cancer, benign prostate hyperplasia and as prospective male contraceptives. Safe, effective and reversible medical approaches to male contraception are now approaching reality. Azoospermia and severe oligozoo/azoospermia can now be accomplished in the majority of men with combined GnRH antagonists and replacement doses of testosterone. Androgens and androgen-progestogen concentrations will induce azoospermia in over 90% of Asian men and azoospermia or severe oligospermia in Caucasian ethnic groups. Field trials are ongoing to determine whether testosterone administration will be more effective than condoms as contraceptives. True precocious puberty can now be managed more effectively than in the past by suppression of gonadotropin secretion with GnRH analogues. Precocious puberty due to other causes can be treated more effectively with inhibitors of steroidogenesis and blockers of androgen action. Metastatic prostate cancer, previously treatable with either castration or oestrogens, is now amenable to suppression of androgen secretion. GnRH analogues are given either alone or combined with blockers of androgen action. While significant palliative effects are observed with endocrine ablative therapy in most men with Stage C or D prostate cancer, modest increases in duration of survival may be seen. Benign prostate hyperplasia was previously approachable only with surgical intervention. Recent data have suggested that medical treatment with 5 alpha-reductase inhibitors and/or selective alpha-adrenergic blockers may offer non-surgical alternatives in some patients. More data are needed to determine the role of medical management of this common disorder.

Entities:  

Keywords:  Androgens; Biology; Cancer; Contraception; Contraception Research--men; Contraceptive Agents; Contraceptive Agents, Male; Diseases; Endocrine System; Family Planning; Follicle Stimulating Hormone; Genitalia; Genitalia, Male; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone; Male Contraception; Neoplasms; Physiology; Prostate; Spermatogenesis Blocking Agents; Testis; Testosterone; Treatment; Urogenital System

Mesh:

Substances:

Year:  1992        PMID: 1377467     DOI: 10.1016/s0950-351x(05)80158-2

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  7 in total

Review 1.  Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.

Authors:  L B Barradell; D McTavish
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

2.  Fancd2os Reduces Testosterone Production by Inhibiting Steroidogenic Enzymes and Promoting Cellular Apoptosis in Murine Testicular Leydig Cells.

Authors:  Xiang Zhai; Xin-Yang Li; Yu-Jing Wang; Ke-Ru Qin; Jin-Rui Hu; Mei-Ning Li; Hai-Long Wang; Rui Guo
Journal:  Endocrinol Metab (Seoul)       Date:  2022-06-29

Review 3.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

4.  Dose-dependent response to an intratesticular injection of calcium chloride for induction of chemosterilization in adult albino rats.

Authors:  K Jana; P K Samanta; D Ghosh
Journal:  Vet Res Commun       Date:  2002-12       Impact factor: 2.459

5.  Individual variation in fathers' testosterone reactivity to infant distress predicts parenting behaviors with their 1-year-old infants.

Authors:  Patty X Kuo; Ekjyot K Saini; Elizabeth Thomason; Oliver C Schultheiss; Richard Gonzalez; Brenda L Volling
Journal:  Dev Psychobiol       Date:  2015-10-24       Impact factor: 3.038

6.  Use of Exogenous Testosterone for the Treatment of Male Factor Infertility: A Survey of Nigerian Doctors.

Authors:  Olufunmilade Akinfolarin Omisanjo; Stephen Odunayo Ikuerowo; Moruf Adekunle Abdulsalam; Sheriff Olabode Ajenifuja; Khadijah Adebisi Shittu
Journal:  Int J Reprod Med       Date:  2017-08-29

7.  Thyroid and reproductive hormones disruption as well as kallikrein-3 level in dimethyl nitrosamine-induced toxicity: Effects of ascorbate treatment in male wistar rats.

Authors:  Oluwatobi T Somade; Regina N Ugbaja; Olubisi E Adeyi; Damilola M Ogunberu
Journal:  Biochim Open       Date:  2016-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.